clots

Johnson & Johnson, AstraZeneca PLC, and the University of Oxford are doing early stage research into whether potential modifications to their coronavirus vaccines could reduce or eliminate the risk of rare but serious blood clots, the Wall Street Journal reported. Quoting sources described as being close to the process, the journal said that outside scientists … Read more